U.S. Markets close in 10 mins.

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
70.5101+0.03 (+0.04%)
As of 3:50PM EDT. Market open.
People also watch
Full screen
Previous Close70.4800
Bid70.2500 x 1100
Ask70.2600 x 300
Day's Range69.8400 - 71.3700
52 Week Range63.7600 - 88.8500
Avg. Volume8,066,854
Market Cap92.14B
PE Ratio (TTM)7.45
Earnings DateN/A
Dividend & Yield2.08 (2.95%)
Ex-Dividend Date2017-06-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com3 hours ago

    Gilead: The Worst is Over?

    The sleeping giant has awakened. Which makes it a perfect time for an analyst to start Gilead Sciences' (GILD) stock with a buy rating. It centers on Gilead's valuation, a thesis that "is not new, but is also not necessarily wrong." They explain: While we fully expect Gilead to ultimately (and yes, eventually) pursue and execute on a business development strategy that should prove transformative (and hence render our outlook on the existing business less relevant) we believe concerns around the stock being a "value trap" for investors will soon come to pass.

  • TheStreet.com4 hours ago

    Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout

    The stock has been on fire.

  • Benzinga6 hours ago

    Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold

    Biotech stocks have been on a tear in the past week, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) up 8.8 percent. However, despite the run-up, Deutsche Bank sees more upside ahead for ...